Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study
References (19)
- et al.
Treatment of psoriasis with etretin: a preliminary report
Mayo Clin Proc
(1987) - et al.
Acitretin versus etretinate in psoriasis
J Am Acad Dermatol
(1988) - et al.
A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis
J Am Acad Dermatol
(1989) - et al.
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative
J Invest Dermatol
(1978) - et al.
Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres
Lancet
(1981) - et al.
Multiple dose pharmacokinetics of Ro 10-1670, the main metabolite of etretinate (Tigason)
- et al.
Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients
Pharm Tox
(1988) - et al.
Clinical pharmacology of 3 generations of retinoids
Dermatologica
(1987) - et al.
Clinical efficacy of Ro 10-1670, the main metabolite of Tigason
There are more references available in the full text version of this article.
Cited by (160)
Role of phototherapy in the era of biologics
2021, Journal of the American Academy of DermatologyJoint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
2020, Journal of the American Academy of DermatologySystemic Retinoids
2020, Comprehensive Dermatologic Drug Therapy, Fourth EditionThe Science and (Lost) Art of Psoralen Plus UVA Phototherapy
2020, Dermatologic ClinicsJoint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy
2019, Journal of the American Academy of DermatologyPsoralen-Ultraviolet Light A Therapy
2016, Therapy for Severe Psoriasis
Supported by a grant from F. Hoffmann-La Roche & Co. Ltd.
Copyright © 1991 Published by Mosby, Inc.